PRESS RELEASE : CompuGroup Medical confirms guidance and mid-term growth targets at virtual Annual General Meeting

DGAP-News: CompuGroup Medical SE & Co. KGaA / Key word(s): AGM/EGM 
CompuGroup Medical confirms guidance and mid-term growth targets at virtual Annual General Meeting 
2021-05-19 / 13:46 
The issuer is solely responsible for the content of this announcement. 
=---------------------------------------------------------------------------------------------------------------------- 
Koblenz. CompuGroup Medical SE & Co. KGaA - one of the leading e-health companies in the world - today successfully 
held its virtual Annual General Meeting (AGM). The resolutions on the dividend payment, the purchase and use of 
treasury shares, the remuneration system and the discharge of the executive and supervisory boards were passed with 
convincing majorities. The management confirmed the guidance for the current year and mid-term growth targets. 
The attendance at today's AGM, which was held as a virtual meeting for the second time due to the ongoing COVID-19 
pandemic, was about 83 % of total share capital. The resolution on the appropriation of profits including the proposed 
dividend of EUR 0.50 was passed with a majority of 99.9 %. The AGM also passed resolutions on the approval of the 
actions of the former Management Board, the current General Partner and the former and the current Supervisory Boards, 
the purchase and use of treasury shares and the remuneration system for the Managing Directors and Supervisory Board, 
each with convincing majorities of more than 75 % of the votes. 
"CompuGroup Medical achieved record revenues of EUR 837 million in the financial year 2020 - a remarkable increase of 
12 %. At the same time, the adjusted EBITDA increased by 8 % to EUR 215 million," said CEO Dr. Dirk Wössner and added, 
"Worldwide, the COVID-19 pandemic has proven in a dramatic way how crucial well-functioning, efficient healthcare is, 
and which opportunities arise from digitization of the processes, data processing and information exchange. Many 
governments have recognized the urgent need for action and have set up large investment programs in the billions, in 
some cases." 
In his speech, Dirk Wössner confirmed the guidance for the current financial year, envisaging more than EUR 1 billion 
in revenues and an adjusted EBITDA in the range of EUR 210 - 230 million. And he emphasized that CGM is targeting 
significant growth in the future from enhancing services for healthcare professionals with new functionalities, patient 
portals, synergies and scale effects from the two large acquisitions in the hospital business and the US market, from 
additional modules in Telematics Infrastructure, new data services and by digitization initiatives such as the Hospital 
Future Act in Germany. 
Dirk Wössner: "Beyond 2021, we expect annual organic revenue growth of 5 % and more with the EBITDA margin increasing 
again at the same time." 
Information on the AGM including the full voting results is available at www.cgm.com/agm. 
About CompuGroup Medical SE & Co. KGaA 
CompuGroup Medical is one of the leading e-health companies in the world. With a revenue base of EUR 837 million in 
2020, its software products are designed to support all medical and organizational activities in doctors' offices, 
pharmacies, laboratories and hospitals. Its information services for all parties involved in the healthcare system and 
its web-based personal health records contribute towards safer and more efficient healthcare. CompuGroup Medical's 
services are based on a unique customer base of more than 1.6 million users, including doctors, dentists, pharmacists 
and other health professionals in inpatient and outpatient facilities. With locations in 18 countries and products in 
56 countries worldwide, CompuGroup Medical is the e-health company with one of the highest coverages among e-health 
service providers. Approximately 8,000 highly qualified employees support customers with innovative solutions for the 
steadily growing demands of the healthcare system. 
Contact for media representatives: 
Michael Franz 
Head of Brand Communication 
P [phone] 
F [phone] 
E-mail: [e-mail] 
Contact for analysts and investors: 
Claudia Thomé 
Corporate Vice President Investor Relations 
P [phone] 
F [phone] 
E-mail: [e-mail] 
=---------------------------------------------------------------------------------------------------------------------- 
2021-05-19 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. 
The issuer is solely responsible for the content of this announcement. 
The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. 
Archive at www.dgap.de 
=---------------------------------------------------------------------------------------------------------------------- 
Language:     English 
Company:      CompuGroup Medical SE & Co. KGaA 
              Maria Trost 21 
              56070 Koblenz 
              Germany 
Phone:        [phone] 
Fax:          [phone] 
E-mail:       [e-mail] 
Internet:     www.cgm.com 
ISIN:         DE000A288904 
WKN:          A28890 
Indices:      MDAX, TecDAX 
Listed:       Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, 
              Hamburg, Munich, Stuttgart, Tradegate Exchange 
EQS News ID:  1198437 
 
End of News   DGAP News Service 
=------------ 

1198437 2021-05-19

 
Image link: 
https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=show_t_gif&application_id=1198437&application_name=news

(END) Dow Jones Newswires

May 19, 2021 07:47 ET (11:47 GMT)